TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
LobSor Pharmaceuticals AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,120
|
3,674
|
2,536 |
Financial expenses |
1
|
10
|
24 |
Earnings before taxes |
3,296
|
4,677
|
-2,727 |
EBITDA |
3,234
|
5,570
|
-1,622 |
Total assets |
9,612
|
7,222
|
6,201 |
Current assets |
6,564
|
3,291
|
1,405 |
Current liabilities |
1,498
|
74
|
3,889 |
Equity capital |
8,115
|
7,148
|
2,102 |
- share capital |
4
|
5
![]() |
5 |
Employees (average) |
3
![]() |
3
|
1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
84.4%
|
99.0%
|
33.9% |
Turnover per employee |
373
|
1,225
|
2,536 |
Profit as a percentage of turnover |
294.3%
|
127.3%
|
-107.5% |
Return on assets (ROA) |
34.3%
|
64.9%
|
-43.6% |
Current ratio |
438.2%
|
4447.3%
|
36.1% |
Return on equity (ROE) |
40.6%
|
65.4%
|
-129.7% |
Change turnover |
-2,256
|
1,184
|
1,755 |
Change turnover % |
-67%
|
48%
|
224% |
Chg. No. of employees |
0
|
2
|
0 |
Chg. No. of employees % |
0%
|
200%
|
0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.